Pharmacovigilance for CAM - An interview with Dr Harald Matthes
RSS feed
Introduction to homeopathic and anthroposophic medicinal products
How to demonstrate the viral safety of homeopathic and anthroposophic preparations of animal origin
A narrative literature review by Eric Baars, newly published in European Journal of Integrative Medicine, explores the benefit/risk balance of using subcutaneous injections.
An HMPWG consultation has now opened on the third list of First Safe Dilutions: send your comments to ECHAMP by 12 September.
The fifth list of stocks for which homeopathic use is justified is now available on the HMPWG website.
ECHAMP is compiling comments on two HMPWG consultations - the fifth list of justified stocks and questions and answers on quality, specifically relating to raw materials.
Key documents from the EU institutions affecting the legal framework for homeopathic and anthroposophic medicinal products
A reference library of EU legal documents that create the legal framework for homeopathic and anthroposophic medicinal products
Concerning the working document presented by María Luisa Carcedo, Minister of Health, Consumers and Social Services and Pedro Duque, Minister of Science, Innovation and Universities in the Instituto de Salud Carlos III on November the 13th, called "PLAN PARA LA PROTECCIÓN DE LA SALUD FRENTE A LAS PSEUDOTERAPIAS"
Clinical data and research in homeopathy and anthroposophic medicine
HMPWG’s new ‘Questions and answers document on regulatory and legal issues concerning homeopathic medicinal products’ confirms the high legal and regulatory standards for these products within the medicinal products legislation in Europe.
The state of Bavaria in South East Germany has announced the establishment of a new department within the Ministry of Health with a focus on integrative medicine.
Stakeholder meeting and regulatory expert event
The sceptics released a manifesto with a mere 2750 signatories from 44 countries. They title suggests a worldwide endorsement even though the organizations who coordinated it, are European.
The STADA Health Report provides a snapshot of what the people of Europe think about the future of health: one fifth relies on alternative treatments such as homeopathy, acupuncture or functional foods in addition to classical medicine. Serbia, Austria and Switzerland all demonstrate above average openness to such alternatives.
Pharmaceutical strategy and Board of Management meeting
A new survey shows that 800,000 residents of Campania in South-West Italy use homeopathic medicines, and one fifth of those have done so for over a decade. 90% of users think it is very or quite important for politicians to pay attention to these medicines.
Important sector events planned for 2021
Political affairs, alignment with stakeholders, News, upcoming meetings and participation in meetings
The findings of recent reviews of controlled homeopathic clinical trials were identified and matched with experimental data from toxicological studies in order to clarify what is known and not known about the material risks of homeopathic medicines.
Membership Assembly, Board of Management, Political affairs, PR & communication - social media, Regulatory affairs expert event, new and upcoming meetings.
ECHAMP’s 2019 Annual Report is now available to download from our website.
Internal briefing for ECHAMP Members
Click through for an update on various useful resources from HRI.
“Progress in implementation of EU legislation for homeopathic medicinal products must be protected and further developed.” Gesine Klein, President, ECHAMP
A new analysis of the Vademecum of Anthroposophic Medicines shows that it is possible to document, assess, and aggregate in a systematic and transparent way experiential evidence from a large group of therapy providers for a large number of anthroposophic medicinal products. This study supports the potential of the Vademecum for scientific and regulatory assessment of these medicines.
Regulatory environment, Strategic narrative, Political affairs, Stakeholder meeting, upcoming meetings and participation in meetings
Strategic narrative, regulatory environment, political affairs, office, upcoming meetings and participation in meetings.